12.01.25 -- Funding Diversity Where It Starts — At the Site

Outdated budgeting slows oncology trials. Real-world site cost data enables faster planning, smoother startup, and better patient care through smarter, evidence-based financial decisions.

Sites are frequently overwhelmed with the sheer number of technologies they must work with to conduct a clinical trial, and this aggregation platform can streamline trial management.

Clinical trials often struggle with enrollment, delaying the delivery of therapies and making access to recent, accurate site data crucial for informed decision making.

Discover how MRN’s CEO Stuart Redding leads efforts to bring clinical trials to patients' homes, workplaces, and communities, enhancing accessibility across all trial phases.

Improve your neuromuscular and neurodegenerative trial's recruitment, retention, and satisfaction by aligning trial design with patient and caregiver needs using a 360° patient-centric model.

We examine the critical disconnect in a patient's understanding and how purpose-built AI platforms can translate complex medical language into plain, accessible communication.

Download our guide to learn proven strategies for designing early phase clinical trials that successfully enroll diverse populations and meet FDA diversity guidance.

Condition-based matching is replacing the inefficient, study-by-study model with a patient-centric approach that matches individuals to all relevant trials based on their unique medical profiles.

By integrating strategy, communication, and measurement, this system offers a structured method for improving engagement and advancing more effective, inclusive research experiences.

One platform is transforming the participant journey to deliver a 60% reduction in participant drop-out and 97% engagement rates, improving retention for even the most vulnerable populations.